Form 4 for TNON Tenon Medical, Inc.
Accepted 2026-09-11 14:13:43 ET · period of report 2026-08-26 · accession 0001475597-26-000240 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-11 14:13 | 2026-09-08+ | TNON | HRT FINANCIAL LP | 10% | P - Purchase | $3.54 | +108.1K | 15.8K | New | +$383.0K |
| M | 2026-09-11 14:13 | 2026-09-09+ | TNON | HRT FINANCIAL LP | 10% | S - Sale | $4.28 | -125.9K | 15.8K | -89% | -$538.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-08 | P | A | 707 | $3.34 | 2,653 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Common Stock | 2026-09-09 | S | D | 50,395 | $2.61 | 18,182 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F2) Resulting in short sales. |
| 3 | Common | Common Stock | 2026-09-09 | P | A | 39,508 | $3.40 | 18,182 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F2) Resulting in short sales. |
| 4 | Common | Common Stock | 2026-09-09 | S | D | 9,948 | $4.27 | 18,182 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F2) Resulting in short sales. |
| 5 | Common | Common Stock | 2026-09-10 | P | A | 31,227 | $2.92 | 15,839 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F2) Resulting in short sales. |
| 6 | Common | Common Stock | 2026-09-10 | P | A | 28,267 | $4.02 | 15,839 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F2) Resulting in short sales. |
| 7 | Common | Common Stock | 2026-09-10 | P | A | 8,431 | $4.92 | 15,839 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F2) Resulting in short sales. |
| 8 | Common | Common Stock | 2026-09-10 | S | D | 65,582 | $5.56 | 15,839 | D | — | — | (F1) We will provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. (F2) Resulting in short sales. |